These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26514291)

  • 21. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes.
    Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y
    Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody.
    Rauscher A; Frindel M; Maurel C; Maillasson M; Le Saëc P; Rajerison H; Gestin JF; Barbet J; Faivre-Chauvet A; Mougin-Degraef M
    Nucl Med Biol; 2014 May; 41 Suppl():e66-74. PubMed ID: 24485990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodistribution and pharmacokinetics of 111In-dTPA-labelled pegylated liposomes after intraperitoneal injection.
    Syrigos KN; Vile RG; Peters AM; Harrington KJ
    Acta Oncol; 2003; 42(2):147-53. PubMed ID: 12801133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography.
    Oku N; Tokudome Y; Tsukada H; Kosugi T; Namba Y; Okada S
    Biopharm Drug Dispos; 1996 Jul; 17(5):435-41. PubMed ID: 8830978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome.
    Wang X; Li Y; Wang D; Wang X; Yuan W; Zhao W; Xia G
    Pharm Dev Technol; 2021 Jan; 26(1):110-118. PubMed ID: 33104406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro and in Vivo Behavior of Liposomes Decorated with PEGs with Different Chemical Features.
    Mastrotto F; Brazzale C; Bellato F; De Martin S; Grange G; Mahmoudzadeh M; Magarkar A; Bunker A; Salmaso S; Caliceti P
    Mol Pharm; 2020 Feb; 17(2):472-487. PubMed ID: 31789523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model.
    Petersen AL; Binderup T; Jølck RI; Rasmussen P; Henriksen JR; Pfeifer AK; Kjær A; Andresen TL
    J Control Release; 2012 Jun; 160(2):254-63. PubMed ID: 22245688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.
    Duan Y; Wei L; Petryk J; Ruddy TD
    Int J Nanomedicine; 2016; 11():5697-5708. PubMed ID: 27843312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Easy and efficient (111)indium labeling of long-term stored DTPA conjugated protein.
    Nalla A; Buch I; Hesse B
    Curr Radiopharm; 2011 Jan; 4(1):1-4. PubMed ID: 22191609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A kit formulation for the preparation of [
    Man F; Khan AA; Carrascal-Miniño A; Blower PJ; T M de Rosales R
    Nucl Med Biol; 2020; 90-91():31-40. PubMed ID: 32979725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics of Zr-89 labeled liposomes over extended periods in a murine tumor model.
    Seo JW; Mahakian LM; Tam S; Qin S; Ingham ES; Meares CF; Ferrara KW
    Nucl Med Biol; 2015 Feb; 42(2):155-63. PubMed ID: 25451215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits.
    Awasthi VD; Garcia D; Goins BA; Phillips WT
    Int J Pharm; 2003 Mar; 253(1-2):121-32. PubMed ID: 12593943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Oct; 188(2):193-202. PubMed ID: 10518675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles.
    Fonge H; Huang H; Scollard D; Reilly RM; Allen C
    J Control Release; 2012 Feb; 157(3):366-74. PubMed ID: 21982897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations.
    Claessens RA; Boerman OC; Koenders EB; Oyen WJ; van der Meer JW; Corstens FH
    Eur J Nucl Med; 1996 Apr; 23(4):414-21. PubMed ID: 8612662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.